Accumulated evidence supports a critical role for abnormal PAK4 expression in oncogenesis, and amplification or activation of PAK4 has been detected in numerous cancers [27–29], including pancreatic, breast, and ovarian cancers [30]. This evidence concerns the gene PAK4 and ovarian carcinoma.